(Q42873435)

English

A Thrombospondin-Mimetic Peptide, ABT-898, Suppresses Angiogenesis and Promotes Follicular Atresia in Pre- and Early-Antral Follicles in Vivo

scientific article published on September 29, 2010

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 November 2017

A thrombospondin-mimetic peptide, ABT-898, suppresses angiogenesis and promotes follicular atresia in pre- and early-antral follicles in vivo (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 November 2017

A Thrombospondin-Mimetic Peptide, ABT-898, Suppresses Angiogenesis and Promotes Follicular Atresia in Pre- and Early-Antral Follicles in Vivo (English)

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

author name string

Jack Henkin

2

1 reference

Europe PubMed Central

PubMed publication ID

9 November 2017

Samantha A. Garside

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20881256

23 July 2024

Keith D. Morris

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20881256

23 July 2024

Suzanne M. Norvell

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20881256

23 July 2024

Fiona H. Thomas

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20881256

23 July 2024

Hamish M. Fraser

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20881256

23 July 2024

language of work or name

0 references

publication date

29 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

9 November 2017

full work available at URL

https://academic.oup.com/endo/article-pdf/151/12/5905/9010595/endo5905.pdf

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20881256

23 July 2024

http://intl-endo.endojournals.org/cgi/content/abstract/151/12/5905

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20881256

23 July 2024

http://academic.oup.com/endo/article-pdf/151/12/5905/9010595/endo5905.pdf

Portable Document Format

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

1 reference

Europe PubMed Central

PubMed publication ID

9 November 2017

151

1 reference

Europe PubMed Central

PubMed publication ID

9 November 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

9 November 2017

5905-5915

1 reference

Europe PubMed Central

PubMed publication ID

9 November 2017

Angiogenic factors

1

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

Role of vascular endothelial growth factor in ovarian physiology and pathology

2

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

Regulation of the ovarian follicular vasculature

3

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

Vascular endothelial growth factor Trap suppresses ovarian function at all stages of the luteal phase in the macaque

4

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

Regulation and action of angiogenic factors in the primate ovary

5

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

SRB Reproduction, Fertility and Development Award Lecture 2008. Regulation and manipulation of angiogenesis in the ovary and endometrium

6

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

Vascular endothelial growth factor receptor 2-mediated angiogenesis is essential for gonadotropin-dependent follicle development

8

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

Endogenous angiogenesis inhibitors

9

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

Angiogenesis: an organizing principle for drug discovery?

10

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

Thrombospondins 1 and 2 function as inhibitors of angiogenesis

11

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity

12

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

Vascular endothelial growth factor stimulates preantral follicle growth in the rat ovary.

13

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth.

14

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

Thrombospondin-1 inhibits VEGF levels in the ovary directly by binding and internalization via the low density lipoprotein receptor-related protein-1 (LRP-1).

15

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

Thrombospondin-1-deficient mice exhibit increased vascular density during retinal vascular development and are less sensitive to hyperoxia-mediated vessel obliteration

16

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

Thrombospondin-1 gene expression affects survival and tumor spectrum of p53-deficient mice

17

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia

18

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressors

19

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor

20

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

Regulation of tumor angiogenesis by thrombospondin-1.

23

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

Thrombospondin-1 inhibits angiogenesis and promotes follicular atresia in a novel in vitro angiogenesis assay.

24

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

Concentration of vascular endothelial growth factor released by cultured human luteinized granulosa cells is higher in women with polycystic ovaries than in women with normal ovaries

25

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

Follicular dynamics in the polycystic ovary syndrome

26

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

Thrombospondin-based antiangiogenic therapy

27

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

ABT-510, a modified type 1 repeat peptide of thrombospondin, inhibits malignant glioma growth in vivo by inhibiting angiogenesis.

28

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

Thrombospondin-1 peptide ABT-510 combined with valproic acid is an effective antiangiogenesis strategy in neuroblastoma

29

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

ABT-510 induces tumor cell apoptosis and inhibits ovarian tumor growth in an orthotopic, syngeneic model of epithelial ovarian cancer

30

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

Preclinical evaluation of antiangiogenic thrombospondin-1 peptide mimetics, ABT-526 and ABT-510, in companion dogs with naturally occurring cancers

31

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

A phase I study assessing the safety and pharmacokinetics of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 with gemcitabine and cisplatin in patients with solid tumors

32

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

Phase I study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 with 5-fluorouracil and leucovorin: a safe combination.

33

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

Phase I safety, pharmacokinetic, and pharmacodynamic study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 in patients with advanced cancer

34

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

A phase II study of ABT-510 (thrombospondin-1 analog) for the treatment of metastatic melanoma

35

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

The effect of the angiogenesis inhibitor TNP-470 on luteal establishment and function in the primate

36

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

Effects of inhibition of vascular endothelial growth factor at time of selection on follicular angiogenesis, expansion, development and atresia in the marmoset

37

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

Angiogenesis in the primate ovary

38

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

Inhibin secretion during the ovulatory cycle and pregnancy in the common marmoset monkey

39

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

Changes in follicle-stimulating hormone and follicle populations during the ovarian cycle of the common marmoset.

40

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

Cloprostenol-induced luteolysis in the marmoset monkey (Callithrix jacchus)

41

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

Administration of vascular endothelial growth factor Trap during the 'post-angiogenic' period of the luteal phase causes rapid functional luteolysis and selective endothelial cell death in the marmoset

43

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

Expression of anti-Mullerian hormone protein during early follicular development in the primate ovary in vivo is influenced by suppression of gonadotropin secretion and inhibition of vascular endothelial growth factor.

44

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

Cell kinetic studies of follicular atresia in the mouse ovary

45

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

Angiogenesis in developing follicle and corpus luteum.

46

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

Vascular endothelial growth factor: basic science and clinical progress

47

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

Expression and localization of thrombospondin-1 and -2 and their cell-surface receptor, CD36, during rat follicular development and formation of the corpus luteum.

48

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

Thrombospondin and vascular endothelial growth factor are cyclically expressed in an inverse pattern during bovine ovarian follicle development

49

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells

50

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

Thrombospondin-1 modulates vascular endothelial growth factor activity at the receptor level

51

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

Vascular endothelial growth factor (VEGF), matrix metalloproteinase-9 (MMP-9), and thrombospondin-1 (TSP-1) expression in urothelial carcinomas

52

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

Thrombospondin-1 modulates angiogenesis in vitro by up-regulation of matrix metalloproteinase-9 in endothelial cells

53

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

Macrophage matrix metalloproteinase-9 regulates angiogenesis in ischemic muscle

54

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

Metformin decreases angiogenesis via NF-kappaB and Erk1/2/Erk5 pathways by increasing the antiangiogenic thrombospondin-1.

55

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

Thrombospondin-1 expression is increased during follicular atresia in the primate ovary

56

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

Changes in thrombospondin-1 levels in the endothelial cells of the anterior pituitary during estrogen-induced prolactin-secreting pituitary tumors

58

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

Thrombospondin-1 induces endothelial cell apoptosis and inhibits angiogenesis by activating the caspase death pathway

60

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1

61

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

Vascular endothelial growth factor and its receptor, Flk-1/KDR, are cytoprotective in the extravascular compartment of the ovarian follicle

62

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

Serum vascular endothelial growth factor concentrations and ovarian stromal blood flow are increased in women with polycystic ovaries.

63

1 reference

10.1210/EN.2010-0283

https://api.crossref.org/works/10.1210/EN.2010-0283

23 July 2024

Identifiers

10.1210/EN.2010-0283

1 reference

Europe PubMed Central

PubMed publication ID

9 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42873435&oldid=2212365353"